Literature DB >> 12531617

Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.

T G St Pierre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12531617     DOI： 10.1016/s0140-6736(03)12221-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  Improved R2* measurements in myocardial iron overload.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Thomas D Coates; Marvin D Nelson; John C Wood
Journal:  J Magn Reson Imaging       Date:  2006-01       Impact factor: 4.813

2.  MRI detects myocardial iron in the human heart.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Ignacio Gonzalez; Marvin D Nelson; Thomas D Coates; John C Wood
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

3.  Cardiac iron determines cardiac T2*, T2, and T1 in the gerbil model of iron cardiomyopathy.

Authors:  John C Wood; Maya Otto-Duessel; Michelle Aguilar; Hanspeter Nick; Marvin D Nelson; Thomas D Coates; Harvey Pollack; Rex Moats
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

Review 4.  MRI evaluation of tissue iron burden in patients with beta-thalassaemia major.

Authors:  Maria I Argyropoulou; Loukas Astrakas
Journal:  Pediatr Radiol       Date:  2007-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.